Cargando…

NAFLD and liver transplantation: Disease burden, current management and future challenges

Non-alcoholic fatty liver disease (NAFLD), specifically its progressive form non-alcoholic steatohepatitis (NASH), represents the fastest growing indication for liver transplantation in Western countries. Diabetes mellitus, morbid obesity and cardiovascular disease are frequently present in patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burra, Patrizia, Becchetti, Chiara, Germani, Giacomo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607500/ https://www.ncbi.nlm.nih.gov/pubmed/33163950 http://dx.doi.org/10.1016/j.jhepr.2020.100192

Ejemplares similares

Management of bacterial infection in the liver transplant candidate
por: Ferrarese, Alberto, et al.
Publicado: (2018)

Liver Transplantation for Alcoholic Liver Disease and Hepatocellular Carcinoma
por: Burra, Patrizia, et al.
Publicado: (2018)

Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management
por: Battistella, Sara, et al.
Publicado: (2023)

Advances and Controversies in Acute Alcohol-Related Hepatitis: From Medical Therapy to Liver Transplantation
por: Germani, Giacomo, et al.
Publicado: (2023)

New Indications for Liver Transplantation
por: Zanetto, Alberto, et al.
Publicado: (2021)

The Role of Antiviral Prophylaxis in Preventing HBV and HDV Recurrence in the Setting of Liver Transplantation
por: Battistella, Sara, et al.
Publicado: (2023)

Recurrence of fatty liver disease following liver transplantation for NAFLD-related cirrhosis: Current status and challenges
por: Dooghaie Moghadam, Arash, et al.
Publicado: (2020)

Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future
por: Reinson, Tina, et al.
Publicado: (2023)

Invasive fungal infection before and after liver transplantation
por: Ferrarese, Alberto, et al.
Publicado: (2020)

Current Management of NAFLD
por: MUNTEANU, MIHAI ALEXANDRU, et al.
Publicado: (2016)

Medical management of metabolic and cardiovascular complications after liver transplantation
por: Becchetti, Chiara, et al.
Publicado: (2020)

Screening for NAFLD—Current Knowledge and Challenges
por: Forlano, Roberta, et al.
Publicado: (2023)

Extracellular Vesicles in Liver Transplantation: Current Evidence and Future Challenges
por: De Stefano, Nicola, et al.
Publicado: (2023)

Current and future pharmacological therapies for NAFLD/NASH
por: Sumida, Yoshio, et al.
Publicado: (2017)

Sex bias in clinical trials in gastroenterology and hepatology
por: Burra, Patrizia, et al.
Publicado: (2022)

Recent Advances in the Management of Acute Variceal Hemorrhage
por: Zanetto, Alberto, et al.
Publicado: (2021)

Management of Hepatocellular Carcinoma Recurrence after Liver Transplantation
por: Pelizzaro, Filippo, et al.
Publicado: (2021)

Liver Transplantation for Colorectal Liver Metastases: Current Management and Future Perspectives
por: Puia-Negulescu, Serban, et al.
Publicado: (2021)

Long-Term Impact of Direct-Acting Antivirals on Liver Fibrosis and Survival in HCV-Infected Liver Transplant Recipients
por: Gambato, Martina, et al.
Publicado: (2023)

Current Options and Future Directions for NAFLD and NASH Treatment
por: Zhang, Chunye, et al.
Publicado: (2021)

New Perspectives in Liver Transplantation: From Regeneration to Bioengineering
por: Bizzaro, Debora, et al.
Publicado: (2019)

Nash Up, Virus Down: How the Waiting List Is Changing for Liver Transplantation: A Single Center Experience from Italy
por: Ferrarese, Alberto, et al.
Publicado: (2022)

Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study
por: Ferrarese, Alberto, et al.
Publicado: (2018)

Artificial Intelligence in NAFLD: Will Liver Biopsy Still Be Necessary in the Future?
por: Zhang, Lei, et al.
Publicado: (2022)

COVID-19 in Liver Transplant Recipients: A Systematic Review
por: Becchetti, Chiara, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
por: Mikolasevic, Ivana, et al.
Publicado: (2018)

Management of bacterial and fungal infections in end stage liver disease and liver transplantation: Current options and future directions
por: Righi, Elda
Publicado: (2018)

Dietary Risks for Liver Mortality in NAFLD: Global Burden of Disease Data
por: Paik, James M., et al.
Publicado: (2021)

Telomeres, NAFLD and Chronic Liver Disease
por: Donati, Benedetta, et al.
Publicado: (2016)

Nutritional Management of Insulin Resistance in Nonalcoholic Fatty Liver Disease (NAFLD)
por: Conlon, Beth A., et al.
Publicado: (2013)

Cholangiocarcinoma as an Indication for Liver Transplantation in the Era of Transplant Oncology
por: Gringeri, Enrico, et al.
Publicado: (2020)

Influence of sex in alcohol‐related liver disease: Pre‐clinical and clinical settings
por: Bizzaro, Debora, et al.
Publicado: (2023)

The Burden of Illness of Irritable Bowel Syndrome: Current Challenges and Hope for the Future
por: Hulisz, Darrel
Publicado: (2004)

Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
por: Drescher, Hannah K., et al.
Publicado: (2019)

Inevitability of disease recurrence after liver transplantation for NAFLD cirrhosis
por: Villeret, François, et al.
Publicado: (2023)

Challenges in Treating Charcot-Marie-Tooth Disease and Related Neuropathies: Current Management and Future Perspectives
por: Pisciotta, Chiara, et al.
Publicado: (2021)

Addressing the Burden and Management Strategies for Disparities and Inequities Among Liver Transplant Professionals: The ILTS Experience
por: Andacoglu, Oya, et al.
Publicado: (2023)

Mitochondrial Transplantation in Mitochondrial Medicine: Current Challenges and Future Perspectives
por: D’Amato, Marco, et al.
Publicado: (2023)

European ‘NAFLD Preparedness Index’ — Is Europe ready to meet the challenge of fatty liver disease?
por: Lazarus, Jeffrey V., et al.
Publicado: (2021)

Disease Burden: Progresses Made, Current State, Future Challenges, and Opportunities
por: Wang, Haidong
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i8bj2br6ig7dgo5mkda7hb1iej